Arcadia Biosciences(RKDA) - 2025 Q4 - Annual Results

Arcadia Biosciences, Inc. Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) (In thousands, except share data and per share data) | | | | Year Ended December 31, | | | --- | --- | --- | --- | --- | | | | 2025 | | 2024 | | Revenues: | | | | | | Product | $ | 4,858 | $ | 5,012 | | License | | — | | 7 | | Royalty | | — | | 26 | | Total revenues | | 4,858 | | 5,045 | | Operating expenses (income): | | | | | | Cost of revenues | | 3,098 | | 2,963 | | Research and development | | 9 ...